Heron Debt To Equity from 2010 to 2024
| HRTX Stock | USD 2.95 0.04 1.37% |
Debt To Equity | First Reported 2010-12-31 | Previous Quarter (5.20) | Current Value (4.94) | Quarterly Volatility 3.74609182 |
Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron main balance sheet or income statement drivers, such as Depreciation And Amortization of 3 M, Interest Expense of 4.1 M or Total Revenue of 133.4 M, as well as many exotic indicators such as Price To Sales Ratio of 1.76, Dividend Yield of 0.0 or Days Sales Outstanding of 111. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.
Heron | Debt To Equity |
Latest Heron Therapeuti's Debt To Equity Growth Pattern
Below is the plot of the Debt To Equity of Heron Therapeuti over the last few years. It is a measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets. Heron Therapeuti's Debt To Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heron Therapeuti's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 6.64 % | 10 Years Trend |
|
Debt To Equity |
| Timeline |
Heron Debt To Equity Regression Statistics
| Arithmetic Mean | 0.11 | |
| Coefficient Of Variation | 3,365 | |
| Mean Deviation | 1.82 | |
| Median | 0.02 | |
| Standard Deviation | 3.75 | |
| Sample Variance | 14.03 | |
| Range | 16.808 | |
| R-Value | 0.01 | |
| Mean Square Error | 15.11 | |
| R-Squared | 0.000058 | |
| Significance | 0.98 | |
| Slope | 0.01 | |
| Total Sum of Squares | 196.46 |
Heron Debt To Equity History
About Heron Therapeuti Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Heron Therapeuti income statement, its balance sheet, and the statement of cash flows. Heron Therapeuti investors use historical funamental indicators, such as Heron Therapeuti's Debt To Equity, to determine how well the company is positioned to perform in the future. Although Heron Therapeuti investors may use each financial statement separately, they are all related. The changes in Heron Therapeuti's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Heron Therapeuti's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Heron Therapeuti Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Debt To Equity | (5.20) | (4.94) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Heron Therapeuti Correlation against competitors. For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Heron Stock analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Heron Therapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heron Therapeuti. If investors know Heron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heron Therapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Revenue Per Share 0.92 | Quarterly Revenue Growth 0.14 | Return On Assets (0.25) | Return On Equity (24.09) |
The market value of Heron Therapeuti is measured differently than its book value, which is the value of Heron that is recorded on the company's balance sheet. Investors also form their own opinion of Heron Therapeuti's value that differs from its market value or its book value, called intrinsic value, which is Heron Therapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heron Therapeuti's market value can be influenced by many factors that don't directly affect Heron Therapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heron Therapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heron Therapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heron Therapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.